Literature DB >> 25377690

Toward a comprehensive model of ∆(9)-tetrahydrocannabinol pharmacokinetics using a population pharmacokinetics approach.

Brett C Ginsburg1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25377690     DOI： 10.1007/s40262-014-0210-x

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN： 0312-5963            Impact factor:   6.447


× No keyword cloud information.
  22 in total

Review 1.  A historical overview of chemical research on cannabinoids.

Authors:  R Mechoulam; L Hanus
Journal:  Chem Phys Lipids       Date:  2000-11       Impact factor: 3.329

2.  THC can be detected in brain while absent in blood.

Authors:  Patrick Mura; Pascal Kintz; Véronique Dumestre; Sébastien Raul; Thierry Hauet
Journal:  J Anal Toxicol       Date:  2005 Nov-Dec       Impact factor: 3.367

3.  Subjective and physiological effects after controlled Sativex and oral THC administration.

Authors:  E L Karschner; W D Darwin; R P McMahon; F Liu; S Wright; R S Goodwin; M A Huestis
Journal:  Clin Pharmacol Ther       Date:  2011-02-02       Impact factor: 6.875

Review 4.  Review of biologic matrices (urine, blood, hair) as indicators of recent or ongoing cannabis use.

Authors:  Frank Musshoff; Burkhard Madea
Journal:  Ther Drug Monit       Date:  2006-04       Impact factor: 3.681

Review 5.  Human cannabinoid pharmacokinetics.

Authors:  Marilyn A Huestis
Journal:  Chem Biodivers       Date:  2007-08       Impact factor: 2.408

6.  Effect of marijuana use on outcomes in traumatic brain injury.

Authors:  Brian M Nguyen; Dennis Kim; Scott Bricker; Fred Bongard; Angela Neville; Brant Putnam; Jennifer Smith; David Plurad
Journal:  Am Surg       Date:  2014-10       Impact factor: 0.688

7.  Population pharmacokinetic model of THC integrates oral, intravenous, and pulmonary dosing and characterizes short- and long-term pharmacokinetics.

Authors:  Jules A A C Heuberger; Zheng Guan; Olubukayo-Opeyemi Oyetayo; Linda Klumpers; Paul D Morrison; Tim L Beumer; Joop M A van Gerven; Adam F Cohen; Jan Freijer
Journal:  Clin Pharmacokinet       Date:  2015-02       Impact factor: 6.447

8.  Vaporization as a smokeless cannabis delivery system: a pilot study.

Authors:  D I Abrams; H P Vizoso; S B Shade; C Jay; M E Kelly; N L Benowitz
Journal:  Clin Pharmacol Ther       Date:  2007-04-11       Impact factor: 6.875

9.  Blood levels do not predict behavioral or physiological effects of Δ⁹-tetrahydrocannabinol in rhesus monkeys with different patterns of exposure.

Authors:  Brett C Ginsburg; Lenka Hruba; Armia Zaki; Martin A Javors; Lance R McMahon
Journal:  Drug Alcohol Depend       Date:  2014-03-19       Impact factor: 4.492

Review 10.  Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications.

Authors:  Marisol S Castaneto; David A Gorelick; Nathalie A Desrosiers; Rebecca L Hartman; Sandrine Pirard; Marilyn A Huestis
Journal:  Drug Alcohol Depend       Date:  2014-08-18       Impact factor: 4.492
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.